A 4-week study to investigate the relationship between resolution of acid-associated heartburn symptoms and dose of esomeprazole magnesium

Trial Profile

A 4-week study to investigate the relationship between resolution of acid-associated heartburn symptoms and dose of esomeprazole magnesium

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Nov 2010

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Gastro-oesophageal reflux; Heartburn
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2009 Results presented at the 74th Annual Scientific Meeting of the American College of Gastroenterology.
    • 01 Apr 2009 Additional location identified as reported by ClinicalTrials.gov.
    • 06 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top